Pharmaceutical agents from filamentous marine cyanobacteria.


Filamentous marine cyanobacteria have emerged as an important source of novel lead compounds for drug discovery and development. The majority of these molecules are nitrogen-containing, belonging to the hybrid polyketide-polypeptide structural class. Owing to their specific interactions with cellular targets, several marine cyanobacterial compounds are… (More)
DOI: 10.1016/j.drudis.2013.05.010


Cite this paper

@article{Tan2013PharmaceuticalAF, title={Pharmaceutical agents from filamentous marine cyanobacteria.}, author={Lik Tong Tan}, journal={Drug discovery today}, year={2013}, volume={18 17-18}, pages={863-71} }